tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avadel Pharmaceuticals sees Q3 revenue $71M-$75M, consensus $70.61M
PremiumThe FlyAvadel Pharmaceuticals sees Q3 revenue $71M-$75M, consensus $70.61M
1d ago
AVDL Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AVDL Earnings this Week: How Will it Perform?
3d ago
Avadel Pharmaceuticals Elects New Board and Auditor
Premium
Company Announcements
Avadel Pharmaceuticals Elects New Board and Auditor
10d ago
Avadel Pharmaceuticals: Promising Outlook with Orphan Drug Designation and Market Expansion for LUMRYZ
PremiumRatingsAvadel Pharmaceuticals: Promising Outlook with Orphan Drug Designation and Market Expansion for LUMRYZ
2M ago
Avadel Pharmaceuticals Receives FDA Orphan Drug Designation
Premium
Company Announcements
Avadel Pharmaceuticals Receives FDA Orphan Drug Designation
2M ago
Avadel Pharmaceuticals announces LUMRYZ granted ODD from U.S. FDA
Premium
The Fly
Avadel Pharmaceuticals announces LUMRYZ granted ODD from U.S. FDA
2M ago
Avadel Pharmaceuticals reports Q1 EPS (5c), consensus (7c)
PremiumThe FlyAvadel Pharmaceuticals reports Q1 EPS (5c), consensus (7c)
3M ago
Avadel Pharmaceuticals sees FY25 revenue $255M-$265M, consensus $249.16M
Premium
The Fly
Avadel Pharmaceuticals sees FY25 revenue $255M-$265M, consensus $249.16M
3M ago
Avadel Pharmaceuticals sees Q2 revenue $60M-$63M, consensus $58.21M
Premium
The Fly
Avadel Pharmaceuticals sees Q2 revenue $60M-$63M, consensus $58.21M
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100